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OBJECTIVE: This study used questionnaires to examine the patient-reported satisfaction with 2 hearing implant devices to determine the level of 
overall satisfaction with the devices, which, if any, factors predicted good or poor perceived outcomes, or whether there were any specific aspects 
of the devices where dissatisfaction was apparent.
METHODS: A post-treatment questionnaire survey of 39 adult patients who had received a Vibrant Soundbridge (VSB) or Bonebridge (BB) hear-
ing implant, with at least 3 months of follow-up, was conducted using the Glasgow Benefit Inventory (GBI) and Hearing Device Satisfaction Scale 
(HDSS). Satisfaction scores were compared to pre- and post-operative audiologic outcomes. The correlation between GBI and HDSS scores was 
also examined.
RESULTS: A total of 28 of the 39 patients (72%) responded: 13 with a BB and 15 with a VSB at a mean of 13 months after implantation. The overall 
mean total GBI score was 30, with no significant differences across the groups. The responders generally reported that they were “satisfied” across 
most domains of the HDSS. In the study, 25 of the 28 responders were largely satisfied with their devices but 3 respondents were not. Two were 
known non-users, while one used the device but did not gain the benefit expected. It is instructive to note that all of these dissatisfied recipients 
were close to the manufacturer recommended limits for implantation of their respective devices at the time of surgery.
Certain themes were identified within the patients’ responses, indicating common aspects where satisfaction was poorer.
CONCLUSION: This series of 28 implant recipients demonstrates high levels of satisfaction with implantable hearing devices across 2 different 
validated questionnaires. Implant teams could exercise caution and manage patient expectations if the patients are close to the recommended 
limits of a particular device.
KEYWORDS:  Bonebridge, Vibrant Soundbridge, transcutaneous, quality of life
INTRODUCTION
The hearing implant service in our hospital first started offering semi-implantable active middle ear implants (MEIs) in the form of 
Vibrant Soundbridge (VSB) (Med-El, Innsbrück, Austria) in 2011. The VSB consists of an implanted device and an external sound pro-
cessor. The implant comprises a magnet, a coil, and electronics package placed superior to the mastoid with a conductor link cable 
connected to the floating mass transducer (FMT) in the middle ear. The sound processor is attached to the implanted part by a mag-
net and provides the power and signal to the implant. We subsequently offered the semi-implantable bone conducting implant 
Bonebridge (BB) (Med-El, Innsbrück, Austria) implants from the time of their entry to the UK market in 2012. This implant differs 
from the VSB with the much larger bone conducting floating mass transducer (BC-FMT) attached directly to the rest of the device by 
a malleable connection. A circular defect is created in the bone for the BC-FMT, which is screwed to the temporal bone directly, with 
sound transmission through the screws to the temporal bone. Both devices have a similar external sound processor in common. 
Anecdotally, some recipients reported greater satisfaction with their implant than others did. This study was designed to examine 
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our patients’ satisfaction with their devices and whether there were 
any consistent patterns related to good or poor satisfaction.
MATERIALS AND METHODS
Between 2011 and 2017, 40 patients underwent surgery for implan-
tation of a VSB or BB in our tertiary referral center. Their ages ranged 
from 14 to 81 years. The single patient aged under 18 was excluded, 
and the remaining 39 patients were invited to take part in a ques-
tionnaire survey. Letters inviting them to take part were sent at least 
3 months post-operatively. Patients who were known non-users of 
the device were included. If happy to take part, respondents were 
asked to complete the Glasgow Benefit Inventory (GBI) and Hearing 
device satisfaction scale (HDSS) questionnaires in English. Formal 
ethical approval for this study was not required by our Local Research 
Ethics Committee as no change to patients’ treatment was caused by 
the administration of questionnaires.
The GBI is a validated post-intervention scoring system, which uses 
an 18-question questionnaire. It was originally developed for use in 
ENT surgery and has been widely used to examine a number of dif-
ferent interventions. Respondents score questions between 1 and 
5. Glasgow Benefit Inventory scores were calculated using the stan-
dard method described by the original authors to give general, 
social, physical, and total scores. The resulting scores may range from 
−100 to +100, depending on the level of patient satisfaction, where 
0 is a neutral response and positive scores indicate improvement in 
patient satisfaction. Where patients did not provide a response to 
a question, the calculation of resulting scores is not possible. This 
occurred for 5 questions across the entire cohort, in 3 questions for 
1 patient. As GBI calculations require all questions to be answered, it 
was assumed that the patients had no positive or negative opinion, 
and a score of 3 was recorded in place of the absent response.
The HDSS utilizes a 21-question questionnaire (Figure 1) and is spe-
cifically written to examine satisfaction with hearing aids or hear-
ing implants. It is less widely used but has previously been used in 
a number of studies for examining VSB and BB satisfaction.1-8 Patient 
responses may be “very satisfied,” “satisfied,” “sometimes satisfied/
dissatisfied,” “dissatisfied,” “very dissatisfied,” or “does not apply.” 
The HDSS questionnaire has not been validated, but its questions are 
particularly suited to implants such as those under investigation. The 
authors were unable to retrieve any instructions on questionnaire 
administration or analysis in the published articles identified above. 
Analysis of this score was not possible using the verbal responses, 
which were therefore converted into numerical scores from −2 to 
+2 for “very dissatisfied” to “very satisfied,” respectively.
Patients’ pure tone and speech audiogram outcomes were also 
reviewed and compared to their satisfaction scores using Pearson’s 
rank correlation coefficient.
Mean calculations for groups and subgroups were carried out using 
Microsoft Excel (version 16.38, Microsoft Corporation, Redmond, 
WA, USA). Examination of the correlation between GBI scores and 
half-optimal speech reception thresholds and between GBI and 
HDSS scores was carried out using the R statistical software package 
 (version 4.0.3).9
RESULTS
In total, 28 of the 39 patients who were contacted responded (72%), 
of whom 13 had a BB and 15 had a VSB. The non-respondents 
included 4 BB recipients and 7 VSB recipients. Eighteen of the respon-
dents were female and 10 were male, from a total of 26 female and 
14 male implant recipients. Two of the VSB users were implanted 
bilaterally at the time of administration of the questionnaire. The 
respondents’ ages ranged from 18 to 81 years in the BB subgroup 
and 40 to 78 years in the VSB subgroup.
The time between implant surgery and administration of the ques-
tionnaires ranged from 3.4 to 38 months (mean 13.1 months).
Soundbridge placement was on the incus long process in 5 respon-
dents, incus short process (latterly when couplers for this location 
became available) in 3, stapes head in 3, oval window in 2, and round 
window in 2.
The most common indications for implantation were sensorineural 
and mixed hearing losses with chronic otitis externa or infection. Two 
of the BB recipients who responded had received their implant to 
treat single-sided deafness (SSD).
Two respondents were known to have become non-users of their 
devices. Both had received VSB devices. One had absent stapes arch 
and incus, and bone erosion in the region of the round window, 
likely due to previous cholesteatoma, requiring device placement 
on the round window. The other had no obvious abnormality and 
underwent implantation onto the short process of the incus with-
out difficulty. Both patients had poor bone conduction thresholds 
pre-operatively but were within the manufacturer’s audiological 
criteria for the VSB. Post-operatively, both patients were found to 
have a slight deterioration in their bone conduction thresholds. This 
meant that they were now slightly outside audiological criteria for 
the device in some frequencies. Neither of these 2 patients found 
the device beneficial. Unsurprisingly, both patients gave the poorest 
scores on GBI. One of these patients also failed to respond to many 
of the questions in the HDSS, probably reflecting her non-use of the 
device.
A third VSB recipient scored poorly on HDSS. Her hearing was within 
the manufacturer’s recommended criteria pre-operatively but was 
among the poorest of the study group. She appeared to have no 
change in her unaided audiometry post-operatively, and her speech 
audiometry results were better than those predicted pre-operatively 
in testing using a bone conducting hearing device (BCHD) on soft 
headband. Her dissatisfaction may represent either hearing on the 
borderline for suitability or excessively high patient expectations 
rather than a suboptimal outcome.
Finally, 1 BB recipient gave more neutral GBI and HDSS scores than 
did most of the cohort. He did not appear to have had any adverse 
outcomes, and the device appears to be giving the expected hearing 
result. This patient had previously received a bone conducting hear-
ing device on the opposite side. This may reflect the limited benefit 
of a second device, whether a hearing aid or an implant, compared 
with the benefit of the initial device.
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Figure 1. Hearing Device Satisfaction Scale Questionnaire (HDSS).
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Hearing Device Satisfaction Score
In certain cases, patients failed to respond or responded frequently 
with “does not apply.” This was particularly seen for question 17 
(repair time) by a significant margin. This was seen as a positive out-
come suggesting good reliability of the device and little need for 
repair. Question 16 (telephone use) and question 19 (sound qual-
ity when listening via the telephone) were also often given a “does 
not apply” response suggesting that patients were not using their 
devices with their telephones.
Four questions from the HDSS questionnaire also scored poorly over-
all in the responses compared with other questions. When converted 
into numerical scores: question 16 (telephone use) (0.14), question 
19 (sound quality when listening via the telephone) (0.3), question 4 
(speech in background noise) (0.36), and question 5 (clarity of sound 
and tone) (0.64). Once again, responses relevant to telephone use 
showed poor satisfaction, which, although positive, were just above 
0. The poorer responses for questions 4 and 5 were surprising. The 
number of respondents scoring questions 4 and 5 as “dissatisfied” or 
“very dissatisfied” was small, but this affected the overall response to 
this question. The dissatisfied respondents were principally patients 
whose hearing was near the limit recommended for their device and 
included the non-users. As a significant number of respondents gave 
the “sometimes satisfied/dissatisfied” response, the overall score for 
these domains was poorer than the score for most other domains 
(Table 1).
There was almost no difference in the overall HDSS scores when the 
VSB and BB groups were compared. The responses for question 17 
(repair time) were higher for the VSB group than for the BB group. The 
responses for question 5 (clarity of sound and tone) and question 21 
(sound quality when listening to the television) were higher for the 
BB group than for the VSB group. These differences were not felt clini-
cally significant, and the number of respondents was so small that 
subgroup analysis was unlikely to provide further insights.
Questions related to other aspects of the devices showed very good 
satisfaction in general. Question 1 (overall fit or comfort) (1.46), ques-
tion 10 (handling, manipulation of the device) (1.41), question 11 
(cleaning and maintenance) (1.4), question 12 (reliability) (1.37), and 
question 2 (visibility to others) (1.36) clearly showed high satisfac-
tion levels of patients when compared with other questions. All these 
questions particularly referred to the external sound processors that 
are simple for patients to interact with and to place correctly on the 
underlying implant.
The range of scores possible by converting the HDSS responses to 
a number was small, and so a meaningful comparison was difficult. 
Looking at the scores given by individual patients, these ranged from 
−1.1 to +1.8. The overall mean score of all patients was 0.95, which 
equates approximately with a “satisfied” response. Only 3 patients 
gave overall scores lower than 0. Two of these were non-users of 
VSB devices, both having pre-operative hearing on the borderline 
for suitability for the device and suffering a small but significant 
reduction in bone conduction thresholds post-operatively. The third 
patient also received a VSB but had hearing well within the manufac-
turer’s recommended range and appeared to have good pure tone 
and speech audiometry results on post-operative testing. The reason 
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Glasgow Benefit Inventory
When individual questions in the GBI questionnaire were examined, 
none appeared to show any clearly positive or negative result when 
compared with the other questions.
The GBI scores were calculated for all respondents, and their mean, 
range, and 95% CI values were as follows: GBI general mean 38.1 
(range 95.8- to 100, 95% CI: ±16.2), GBI social mean 14.3 (range 
100 to −16.7, 95% CI: +/- 9.8), GBI physical mean 11.3 (range 100 to 
−66.7, 95% CI: ±14.9), and GBI total mean 29.7 (range 83.3 to −69.4, 
95% CI: ±12.7). The lowest score in the GBI physical calculation was 
an outlier, due to a patient who had medical problems unrelated to 
his hearing loss or implant. Scores were calculated separately for the 
2 different devices (Table 2); little difference was seen between the 
2 groups, except in the case of social scores, where VSB recipients 
scored their satisfaction more highly than those receiving BB devices. 
We postulate that this may be because of the greater gain possible 
with the VSB, allowing patients with poorer hearing to receive this 
device and to benefit from greater hearing improvement.
Calculations were also carried out with the 2 device non-users 
removed, so that scores reflecting actual users could be reviewed. 
The following GBI scores were found: GBI general mean 45.8, GBI 
social mean 14.1, GBI physical mean 14.1, and GBI total mean 35.3. 
Unsurprisingly, the scores showed an improvement with non-user 
scores removed from calculations.
Correlation Between PROMs and Audiological Outcomes
Audiological data were incomplete, principally for the earliest 
patients implanted who did not undergo all of our current standard 
schedule of pre-operative audiological assessments or whose data 
could not be retrieved from the audiology systems. Two patients 
receiving a BB for SSD had no pre-operative hearing in the implanted 
ear, so comparison of audiometric outcomes was therefore not pos-
sible. Overall, this meant that 3 patients could not be included in cal-
culations based on the audiometric calculations.
No clear correlation between improvement in speech audiometry 
and GBI scores could be identified. These relationships were exam-
ined using the Pearson correlation coefficient, which was calculated 
for post-operative half-optimal speech reception threshold com-
pared to GBI general score, GBI total score and between change in 
half-optimal speech reception threshold compared to GBI total score. 
The results for these tests were −0.151 (95% CI: −0.496 to 0.235), 
−0.152 (95% CI: −0.497 to 0.234), and −0.0448 (95% CI: −0.432 to 
0.357), respectively. All values were near 0, with 95% CI above and 
below 0, showing no relationship between these outcomes.
Correlation Between PROM Questionnaires
The HDSS questionnaire has not been previously validated. We 
also examined the results from our patients to compare satisfac-
tion according to the GBI total and HDSS outcomes we received. 
This demonstrated a Pearson correlation coefficient of 0.753 (95% 
CI: 0.529-0.879) and P-value of <.0001 (Figure 1). This suggests that 
HDSS closely reflects the outcome of GBI in our group of patients.
DISCUSSION
GBI has been used widely in ENT surgery and in a large number of 
interventions. Previous articles have been published giving GBI 
outcomes for VSB in all FMT placements10-12 as well as specifically in 
round window vibroplasty,13 BB used in all causes of hearing loss11,14 
and in SSD specifically,15 BCHD,11,15-17 Esteem,11 and conventional 
hearing aids.10 An interesting systematic review was also published 
specifically comparing the GBI outcomes between a number of ENT 
interventions, including BCHD and MEI.18 Unfortunately, the hetero-
geneity between the studies of BCHD was high, and so meta-analysis 
could not be carried out, but the mean GBI total score for the papers 
examining MEI outcomes was 16.3 (95% CI: 10.4-22.1).
A summary of the GBI outcomes for similar hearing devices cited in 
the publications above can be seen in Table 3.
Hearing Device Satisfaction Scale has been less widely used in the 
published literature. Böheim et al.5 described its use in VSB implanta-
tion on the round window, and Baumgartner et al.3 described its use 
in a larger multicenter study. These papers describe a pre- and post-
implantation percentage satisfaction score in the results; however, in 
their paper, the authors do not explain how they arrived at this score. 
It was interesting to see that in our group of patients, the HDSS score 
correlated well with the long-established GBI score.
At the time the department first offered VSB, the sound proces-
sor provided with the device did not have any built-in facility to 
communicate with mobile or landline telephones using Bluetooth. 
It also did not include a loop induction system in the device. The 
same device was the standard sound processor at the time of 
release of the BB device. A new sound processor, called Samba, was 
launched at the time of the launch of the current model of VSB in 
Table 2. Calculated GBI Values for All Patients, Recipients of VSB and BB
General Social Physical Total
All Devices 38.1 14.3 11.3 29.7
VSB 36.4 17.8 8.9 28.7
BB 40.1 10.3 14.1 30.8
Table 3. Comparison of Mean GBI Total Scores, ± Standard Deviation (SD) 
or 95% Confidence Interval (CI), Where Available, for Hearing Devices in 
Different Studies
VSB BB BCHD Hearing Aid
Jones et al. 28.7 ± 95% CI: 
21.5, n = 15
30.8 ± 95% 
CI: 15.3, 
n = 13
Ihler et al.10,14 38.3 ± SD: 
32.3, n = 10
32.4 ± SD: 
13.5
24.8 ± SD: 
22.2, n = 12
Monini et al.11 36.5, n = 10 35.2, n = 4 23, n = 27
Ho et al.16 38 95% CI: 





20.1 ± SD: 
16.0, n = 33
Lassaletta 
et al.13




31 ± 95% 
CI 9, n = 51
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2015. This does allow connection to Bluetooth and loop systems 
via an additional device. The Siemens miniTek device (Siemens AG, 
Munich, Germany) is included for patients undergoing implanta-
tion with either device in the UK. All of our patients who underwent 
surgery since 2015 have received the new device and will have 
the miniTek. Some of the earlier patients may also have required a 
newer sound processor, which also functions with the earlier model 
of VSB implants. It does not appear that the satisfaction scores in 
HDSS differ greatly between the earlier and later patients. This may 
reflect difficulties the audiologists have had in pairing the miniTek 
with patients’ phones or the dissatisfaction with the requirement 
to carry a second device so that their implants will work with their 
phones.
The overall satisfaction scores on both questionnaires were positive. 
The mean overall score on HDSS was 0.95, which would equate to an 
overall “satisfied” response. The scores on GBI were all positive, and 
the results in all domains were comparable with those in similar stud-
ies. Further work with a larger patient cohort may allow us to assess 
for the evidence of correlation between subgroups and quality-of-
life measures.
Two of the patients who took part in this study were non-users of 
their MEI device. In both cases, their pre-operative hearing was 
within the recommended limit; however, their bone conduction 
thresholds deteriorated only slightly per-operatively, taking them 
outside recommended thresholds. This serves as a reminder that sur-
gery or other causes may result in progression of hearing loss. When 
considering patients at or near the limit of the implant for surgery, 
it is important to consider this possibility and to counsel the patient 
appropriately. It was unsurprising that the 2 non-users gave the 
poorest satisfaction scores.
Although some complications were seen and some implant recipi-
ents became non-users, the overall levels of satisfaction with both 
VSB and BB were high. This series compares well with other similar 
series and demonstrates that these devices have a place in rehabilita-
tion of patients with hearing loss.
The group of patients who scored most poorly in both question-
naires were those whose hearing was near the limits of the manufac-
turer’s recommendations for suitability. Patients such as this should 
be considered carefully and counseled pre-operatively to ensure that 
their expectations of the device are realistic.
Themes of poorer satisfaction with the devices were found with the 
HDSS question that related to telephone use. We believe this may be 
due to the difficulties with lack of connectivity using either Bluetooth 
or loop induction in earlier sound processors and problems with 
connection via Bluetooth in more recent devices. We hope that this 
will be addressed in future updates to the sound processor for both 
devices.
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